FDA Recalls Vancomycin Injectable Solution Due to Sterility Concerns
Central Admixture Pharmacy Services is recalling 8,252 bags of vancomycin injection nationwide after FDA inspection raised concerns about product sterility. Affected lots expire May through June 2023.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of injectable medication with sterility assurance concerns. No illnesses or injuries reported in the source. Per the rubric, risk-of-harm products where injury has not been documented qualify as High (3) severity.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 8,252 bags of vancomycin added to 0.9% sodium chloride solution (1.75 g/500 mL, 3.5 mg/mL) distributed nationwide in the USA. The recall was initiated after an FDA inspection raised questions about the sterility of these injectable products.
Injectable medications require sterility to prevent contamination and patient harm. The loss of sterility assurance in these products poses a potential risk. Multiple lots are affected, with expiration dates ranging from May 3, 2023 through June 26, 2023. Affected products are identified by NDC 71285-7060-1.
Patients and healthcare providers who possess affected lots should not use these products. Patients should consult their healthcare provider, and healthcare providers should contact the manufacturer for replacement products and further guidance.
The recalled product
- Product
- vancomycin added to 0.9% sodium chloride, 1.75 g/500 mL* (3.5 mg/mL), 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7060-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Affected units
- 8,252
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # 37-884152
- 37-884158
- Exp 05/03/2023
- 37-885300
- 37-885302
- 37-885307
- Exp 05/08/2023
- 37-887418
- 37-887431
- 37-887432
- Exp 05/16/2023
- 37-888850
- 37-888852
- 37-888853
- Exp 05/22/2023
- 37-889188
- Exp 05/23/2023
- 37-890892
- 37-890894
- 37-890897
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 108 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 108 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22